Making vaccines "on demand": a potential solution for emerging pathogens and biodefense? - sprookjes - yvandenbroek - TriplyDB

Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?

Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?

http://www.wikidata.org/entity/Q30222126

about

Agility in adversity: Vaccines on Demand Middle East respiratory syndrome: obstacles and prospects for vaccine development Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases.Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice.Report from the field: Overview of the Sixth Annual Vaccine Renaissance Conference ICoVax 2013: the 3rd ISV Pre-conference Computational Vaccinology Workshop.Vaccines 'on demand': science fiction or a future reality.Innovation, urgency and acceptance at the 9th Vaccine Renaissance.

P2860

Q26252583-14F55931-ACB6-4FB9-A8FE-5562BA9CE589 Q27013314-A18D7FF7-29EE-4E38-B68A-5A007C1C049D Q36550981-E2FA2B6B-3EB3-4A22-93CE-C81FF27C29E7 Q38559266-D8F93639-595C-48A0-8E19-C06E06589EF0 Q40744757-009203A8-57E7-4624-8A60-7E6DDD31C520 Q42379418-369F380D-74A9-428D-8B77-AC631D7C61AD Q42727388-6F8E0752-440B-4BFC-9E77-3A729D3FBA91 Q44095960-1D40D3BF-A75F-4D5A-AA2A-2B4C1B5A1FBC Q50285179-07E8A4FE-1DFE-43D2-8D37-74583AEFD42A

P2860

Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?

http://www.wikidata.org/entity/Q30222126

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?

@ast

Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?

@en

type

label

Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?

@ast

Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?

@en

prefLabel

Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?

@ast

Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?

@en

P1433

Q30222126-C51256B8-01B4-4EF4-BCBB-EC77E08F84F2

P1476

Q30222126-961AF65F-9111-4494-A2FB-A5F1C49DCFBE

P2093

Q30222126-09D38582-626E-4895-AB8E-E815AB5D8248

Q30222126-0FEA4594-2521-4B9C-B5DC-702406C23761

Q30222126-45047760-6B0D-4854-BE83-CBC01856FFF0

Q30222126-C8BACF6D-5652-4177-ADE6-A717ED763297

Q30222126-DC9FF5B7-5DCC-4A51-8576-49CC80B436D3

Q30222126-F8F8421B-7090-441C-9DAD-CA540EDC40A3

P275

Q30222126-8DBB4C56-D003-4EA5-AEB4-4CA8F9A5928E

P2860

Q30222126-1CF87F31-764C-4562-B20A-B54F4FC55AA3

Q30222126-1D220ABE-D822-4755-B4D6-41B71DF37E97

Q30222126-2F716BC2-2FE1-417C-9156-01A459BFB797

Q30222126-30681F3D-203A-44BE-8FBC-775376864A64

Q30222126-307B37E2-C366-473E-B601-0E47C5E11DFE

Q30222126-31F35F2B-6F41-4507-8EEF-C9FE600B4718

Q30222126-37BC23E4-CD87-48FF-89C9-34FA1E636D1B

Q30222126-3E7ADB88-FE0E-4EC2-8C63-7A8C07A975FD

Q30222126-3F889B66-3ABD-4B21-842E-FEFD62F000BF

Q30222126-3FE929BD-9E3F-4060-9B98-5E2BE9132B10

P304

Q30222126-C0EC1DDC-C4B7-46FA-94FC-C9E1E5E81B8C

P31

Q30222126-09426C85-D085-4215-8987-118CFD4600DD

Q30222126-2110E4F9-1176-4E01-B108-DBCE767E8EA4

P356

Q30222126-4B63A9DE-BCCF-4435-85D8-1F6E205065D8

P433

Q30222126-DFD5A72B-29B2-45D3-AA38-CE77A8B9297A

P478

Q30222126-A37DBF02-127D-45FA-AD4B-47BA56E5292C

P50

Q30222126-46921164-02BE-4392-B45A-C7308505A986

Q30222126-EACD3426-B7B8-4AEA-A919-1003623F7F70

P577

Q30222126-7C91B4E0-7EB2-44CA-A6D9-9CE644003771

Q30222126-86D3726F-E032-4FAC-A286-23695EC9B357

P5875

Q30222126-ED348A79-F08D-4144-BE98-82B26A162450

P698

Q30222126-56649F0A-EEDC-4C8B-AEB7-585609825407

P921

Q30222126-2FC6EBE5-4D77-41C1-BD18-B99A0BD148EF

Q30222126-7E15A977-8C6A-46C2-941D-AC06FAE68585

Q30222126-F164D60D-1B51-4B7D-9210-57E377553B97

P932

Q30222126-CF80A73B-22FE-4311-9D4D-CB6A125ED12A

P356

P1433

Human Vaccines & Immunotherapeutics

P1476

Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?

@en

P2093

John Ballantyne

http://www.w3.org/2001/XMLSchema#string

Leo Einck

http://www.w3.org/2001/XMLSchema#string

Matthew Ardito

http://www.w3.org/2001/XMLSchema#string

Michael Chambers

http://www.w3.org/2001/XMLSchema#string

Robert W Malone

http://www.w3.org/2001/XMLSchema#string

William Martin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 3.0 Unported

P2860

Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population

Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis

Proteomics in Vaccinology and Immunobiology: An Informatics Perspective of the Immunone

Development of Burkholderia mallei and pseudomallei vaccines

CTLA-4 blockade in tumor models: an overview of preclinical and translational research

West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays.

Rapid Determination of HLA B*07 Ligands from the West Nile Virus NY99 Genome

Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression

HIV vaccine development by computer assisted design: the GAIA vaccine

Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines

P304

1877-1884

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.25611

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Anne Searls De Groot

P577

2013-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264534308

http://www.w3.org/2001/XMLSchema#string

P698

23877094

http://www.w3.org/2001/XMLSchema#string

P921

manufactured product

biomedical investigative technique

P932

3906351

http://www.w3.org/2001/XMLSchema#string